Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP)

CUSIP: 13463J101

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
51,990,875
Total 13F shares
12,677,488
Share change
-176,243
Total reported value
$50,710,355
Price per share
$4.00
Number of holders
39
Value change
-$1,002,366
Number of buys
18
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 13463J101?
CUSIP 13463J101 identifies CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) as of Q1 2025

As of 31 Mar 2025, Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,677,488 shares. The largest 10 holders included ENAVATE SCIENCES GP, LLC, 5AM Venture Management, LLC, AH CAPITAL MANAGEMENT, L.L.C., HarbourVest Partners LLC, FMR LLC, FRANKLIN RESOURCES INC, BlackRock, Inc., VANGUARD GROUP INC, Alyeska Investment Group, L.P., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.